Company Intelligence
Exin Therapeutics
Exin Therapeutics provides enterprise-grade artificial intelligence solutions, delivering specialized AI drug discovery platform for neurotherapeutics technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- San Francisco, United States
- Website
- www.exintherapeutics.com
- Founded
- 2025
- Stage
- Early
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Exin Therapeutics is a Healthcare AI company based in San Francisco, United States, founded in 2025.
Exin Therapeutics develops AI drug discovery platform for neurotherapeutics.
What it builds
AI drug discovery platform for neurotherapeutics
Why It Matters
Exin Therapeutics provides enterprise-grade artificial intelligence solutions, delivering specialized AI drug discovery platform for neurotherapeutics technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Exin Therapeutics
Explore Exin Therapeutics by Exin Therapeutics. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,…
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Exin Therapeutics
Industry
Products
Capabilities
- AI drug discovery platform for neurotherapeutics
Features
- AI drug discovery platform for neurotherapeutics
Country
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does Exin Therapeutics do?
Exin Therapeutics specializes in artificial intelligence, developing AI drug discovery platform for neurotherapeutics to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Exin Therapeutics based and when was it founded?
Exin Therapeutics is based in United States and was founded in 2025.
What are the main products offered by Exin Therapeutics?
The flagship platform from Exin Therapeutics is AI drug discovery platform for neurotherapeutics, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Exin Therapeutics?
Exin Therapeutics primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.